Literature DB >> 15923196

1-Oleoyl-2-acetylglycerol stimulates 5-lipoxygenase activity via a putative (phospho)lipid binding site within the N-terminal C2-like domain.

Christina Hörnig1, Dana Albert, Lutz Fischer, Michael Hörnig, Olof Rådmark, Dieter Steinhilber, Oliver Werz.   

Abstract

5-Lipoxygenase (5-LO) catalysis is positively regulated by Ca2+ ions and phospholipids that both act via the N-terminal C2-like domain of 5-LO. Previously, we have shown that 1-oleoyl-2-acetylglycerol (OAG) functions as an agonist for human polymorphonuclear leukocytes (PMNL) in stimulating 5-LO product formation. Here we have demonstrated that OAG directly stimulates 5-LO catalysis in vitro. In the absence of Ca2+ (chelated using EDTA), OAG strongly and concentration-dependently stimulated crude 5-LO in 100,000 x g supernatants as well as purified 5-LO enzyme from PMNL. Also, the monoglyceride 1-O-oleyl-rac-glycerol and 1,2-dioctanoyl-sn-glycerol were effective, whereas various phospholipids did not stimulate 5-LO. However, in the presence of Ca2+, OAG caused no stimulation of 5-LO. Also, phospholipids or cellular membranes abolished the effects of OAG. As found previously for Ca2+, OAG renders 5-LO activity resistant against inhibition by glutathione peroxidase activity, and this effect of OAG is reversed by phospholipids. Intriguingly, a 5-LO mutant lacking tryptophan residues (Trp-13, -75, and -102) important for the binding of the 5-LO C2-like domain to phospholipids was not stimulated by OAG. We conclude that OAG directly stimulates 5-LO by acting at a phospholipid binding site located within the C2-like domain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923196     DOI: 10.1074/jbc.M500068200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor.

Authors:  B Hofmann; C B Rödl; A S Kahnt; T J Maier; A A Michel; M Hoffmann; O Rau; K Awwad; M Pellowska; M Wurglics; M Wacker; A Zivković; I Fleming; M Schubert-Zsilavecz; H Stark; G Schneider; D Steinhilber
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production.

Authors:  Marija Rakonjac; Lutz Fischer; Patrick Provost; Oliver Werz; Dieter Steinhilber; Bengt Samuelsson; Olof Rådmark
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

3.  TRPC channels and diacylglycerol dependent calcium signaling in rat sensory neurons.

Authors:  Michaela Kress; Johannes Karasek; Antonio V Ferrer-Montiel; Nadja Scherbakov; Rainer Viktor Haberberger
Journal:  Histochem Cell Biol       Date:  2008-07-29       Impact factor: 4.304

4.  Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo.

Authors:  Christian Feisst; Carlo Pergola; Marija Rakonjac; Antonietta Rossi; Andreas Koeberle; Gabriele Dodt; Marika Hoffmann; Christina Hoernig; Lutz Fischer; Dieter Steinhilber; Lutz Franke; Gisbert Schneider; Olof Rådmark; Lidia Sautebin; Oliver Werz
Journal:  Cell Mol Life Sci       Date:  2009-07-05       Impact factor: 9.261

5.  Human Dicer C-terminus functions as a 5-lipoxygenase binding domain.

Authors:  Vildan Dincbas-Renqvist; Geneviève Pépin; Marija Rakonjac; Isabelle Plante; Dominique L Ouellet; Andreas Hermansson; Isabelle Goulet; Johanne Doucet; Bengt Samuelsson; Olof Rådmark; Patrick Provost
Journal:  Biochim Biophys Acta       Date:  2008-10-28

Review 6.  Impact of Androgens on Inflammation-Related Lipid Mediator Biosynthesis in Innate Immune Cells.

Authors:  Simona Pace; Oliver Werz
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

7.  Machine intelligence decrypts β-lapachone as an allosteric 5-lipoxygenase inhibitor.

Authors:  Tiago Rodrigues; Markus Werner; Jakob Roth; Eduardo H G da Cruz; Marta C Marques; Padma Akkapeddi; Susana A Lobo; Andreas Koeberle; Francisco Corzana; Eufrânio N da Silva Júnior; Oliver Werz; Gonçalo J L Bernardes
Journal:  Chem Sci       Date:  2018-07-17       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.